SNDLNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

SNDL Inc.

Financials through fiscal 2026, year ended Dec 31, 2025Last filing: 40-F on Mar 12, 2026

$1.25+0.00 (+0.40%)

Close on Oct 19, 2026

Community

Notes and questions about SNDL from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SNDL.

Revenue growth2.8% · median 6.8%

Gross margin27.3% · median 29.1%

Operating margin-0.7% · median -24.3%

Net margin-1.7% · median -48.1%

Advertisement
300 × 250